Home LiteratureArticle Details
PMID: 4840433 Published · ppublish English Journal Article

Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis.

Antimicrobial agents and chemotherapy ·Vol. 5 ·No. 3 ·1974-03-00 ·Pages 228-33

Thornsberry C, Baker CN, Facklam RR

Abstract

Seventy-four strains of Streptococcus bovis and 35 strains of enterococci (Streptococcus faecalis and its varieties, Streptococcus faecium and Streptococcus durans), most of which were isolated from patients with endocarditis, were tested for their susceptibility to penicillin, ampicillin, erythromycin, cephalothin, vancomycin, methicillin, tetracycline, chloramphenicol, kanamycin, streptomycin, and gentamicin. Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) were determined by a microtiter broth dilution technique. All of these organisms are group D streptococci, but the S. bovis strains are not enterococci. On the basis of both MIC and MBC, the S. bovis strains were much more susceptibile in general to antibiotics then were the enterococcal strains. For the S. bovis strains, the lowest MICs were obtained with penicillin, ampicillin, and erythromycin, and the lowest MBCs with penicillin and ampicillin. Although these antibiotics were also the most active against the enterococci, the MICs and MBCs were much higher than obtained with the S. bovis strains. Gentamicin was the most active aminoglycoside. On the basis of in vitro susceptibility results, the S. bovis strains resemble the viridans streptococci rather than enterococci.

MeSH Terms
Anti-Bacterial Agents/pharmacology Endocarditis, Bacterial/microbiology Humans Microbial Sensitivity Tests Streptococcus/drug effects
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Thornsberry C
Baker C N
Facklam R R
References (13)
13 references, click to expand
  1. Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.
    Am J Med Sci. 1969 Dec;258(6):416-30 PMID: 4984452
  2. Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms.
    Ann Intern Med. 1970 Nov;73(5):683-7 PMID: 4990937
  3. THE GROUP D STREPTOCOCCI.
    Bacteriol Rev. 1964 Sep;28:330-66 PMID: 14220658
  4. In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.
    Mayo Clin Proc. 1970 Jul;45(7):527-35 PMID: 5434106
  5. Recognition of group D streptococcal species of human origin by biochemical and physiological tests.
    Appl Microbiol. 1972 Jun;23(6):1131-9 PMID: 4557563
  6. Penicillin and gentamicin therapy for enterococcal infections.
    JAMA. 1973 Feb 26;223(9):1030-2 PMID: 4486588
  7. Taxonomy of enterococci by computer analysis.
    Can J Microbiol. 1966 Apr;12(2):353-62 PMID: 4959245
  8. A numerical taxonomic study of streptococci of serological group D.
    J Gen Microbiol. 1972 Oct;72(3):439-50 PMID: 4629133
  9. Infective endocarditis: past, present and future.
    J R Coll Physicians Lond. 1972 Jan;6(2):161-74 PMID: 4400785
  10. Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations.
    Antimicrob Agents Chemother (Bethesda). 1970;10:195-200 PMID: 5209425
  11. The treatment of endocarditis.
    Am Heart J. 1970 May;79(5):713-6 PMID: 5444458
  12. The application of computers to the classification of streptococci.
    J Gen Microbiol. 1968 Jan;50(1):149-58 PMID: 5635520
  13. THE STREPTOCOCCI.
    Bacteriol Rev. 1937 Dec;1(1):3-97 PMID: 16350049
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1974-03-00
Pages
228-33
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC428953
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]